Fig. 1 · Structure

Documents & Downloads

Lamivudine

Cat. No. A10512 CAS 134678-17-4
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI).

In Stock

Publications for Lamivudine

2 publications citing this product

  1. Masaaki Toyama, .et al. , Antimicrob Agents Chemother, 2022, Jun 21;66(6) PMID: 35604213
  2. Toyama M, .et al. , Virus Res, 2019, Oct 2;271:197677 PMID: 31376401

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Reverse transcriptase

Cellular Effect

Cell Line Activity Value Description Reference
C8166 CC50 > 1000 μM Toxicity in human C8166 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay [PMID: 31310115]
Caco-2 IC50 > 250 μM Cytostatic activity against human Caco2 cells assessed as growth inhibition after 3 days by particle counting analysis [PMID: 24177359]
CCRF-CEM CC50 > 100 μM Cytotoxicity against human CEM cells assessed as reduction in cell viability by MTT assay [PMID: 33421915]
CCRF-CEM IC50 > 100 μM Cytotoxicity against human CEM cells after 6 days by trypan blue exclusion assay [PMID: 21700368]
CCRF-CEM CC50 > 100 μM Cytotoxicity against human CEM cells by CellTiter 96 non-radioactive cell proliferation colorimetric assay [PMID: 28688280]
CCRF-CEM CC50 > 100 μM Cytotoxicity against human CEM cells assessed as growth inhibition by CellTiter 96 non-radioactive cell proliferation colorimetric assay [PMID: 28094179]
CCRF-CEM IC50 > 250 μM Cytostatic activity against thymidine kinase-deficient human CEM cells assessed as growth inhibition after 3 days by particle counting analysis [PMID: 24177359]
CCRF-CEM IC50 > 250 μM Cytostatic activity against human CEM cells assessed as growth inhibition after 3 days by particle counting analysis [PMID: 24177359]
CCRF-CEM EC50 0.099 μM Antiviral activity against HIV1 3B infected in human CEM cells assessed as virus-induced giant cell formation after 4 days by microscopic analysis [PMID: 24177359]
CCRF-CEM EC50 0.18 μM Antiviral activity against HIV2 ROD infected in human CEM cells assessed as virus-induced giant cell formation after 4 days by microscopic analysis [PMID: 24177359]
CCRF-CEM IC50 50 μM Compound was evaluated for cytotoxicity by inhibition of mitochondrial DNA synthesis 10.1016/0960-894X(95)00343-R
CEM-SS ED50 0.36 μM Antiviral activity against HIV1 3B infected in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect after 6 days by MTS assay [PMID: 15217281]
CEM-SS EC50 200 nM Antiviral activity against HIV-1 subtype 3B infected in CEM-SS cells assessed as inhibition of viral replication after 6 days by XTT assay [PMID: 22858097]
CHO IC50 54.2 μM Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits [PMID: 23812503]
COLO 320 IC50 > 250 μM Cytostatic activity against human COLO320 cells assessed as growth inhibition after 3 days by particle counting analysis [PMID: 24177359]
H9 CC50 > 200 μM Cytotoxicity against human H9 cells assessed as cell viability incubated for 7 days by MTT colorimetric assay [PMID: 34245947]
H9 EC50 0.06 μM Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique [PMID: 11430019]
H9 EC50 0.06 μM Antiviral activity against HIV1 RF in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique [PMID: 11430019]
HEK293 EC50 > 300 μM Antiviral activity against HIV1 expressing reverse transcriptase D67N/K70R/T215F/K219E/M184V mutant infected in HEK293 cells assessed as inhibition of virus replication after 72 hrs [PMID: 20308377]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 134678-17-4
Formula C8H11N3O3S
Molecular Weight 229.25
SMILES
C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 39 mg/mL (170.11 mM)
Water 39 mg/mL (170.11 mM)
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Masaaki Toyama, .et al. , Antimicrob Agents Chemother, 2022, Jun 21;66(6) PMID: 35604213
  2. Toyama M, .et al. , Virus Res, 2019, Oct 2;271:197677 PMID: 31376401

Added to your cart

View Cart Checkout
Loading...